Amgen (AMGN) PT Raised to $340 at Truist Securities

July 7, 2026 7:08 AM

Truist Securities analyst Greg Renza raised the price target on Amgen (NASDAQ: AMGN) to $340.00 (from $327.00) while maintaining a Hold rating.

No results found